Physician profile
Keith Volk
NPI 1366923666
$5,253.99
in general payments reported to CMS, 2019-2025
13 companies · $329 in 2025
The $329 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $607 · 2022: $2,167 · 2023: $1,727 · 2024: $424 · 2025: $329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,288 · Food and Beverage: $1,192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,288.32 |
| Food and Beverage | $1,192.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,536.99 | 2021-2025 | Watchman Access System, Watchman |
| Edwards Lifesciences Corporation | $1,182.87 | 2022-2025 | Evoque |
| Abbott Laboratories | $644.83 | 2022-2025 | Cardiomems, Amplatzer Talisman, Xience Skypoint |
| Medtronic, INC. | $466.61 | 2021-2022 | |
| Abiomed | $109.26 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $109.15 | 2022 | |
| Sanofi-Aventis U.S. LLC | $104.18 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $20.24 | 2021 | |
| Novartis Pharmaceuticals Corporation | $19.76 | 2024 | |
| Amgen INC. | $18.40 | 2021 | |
| Janssen Pharmaceuticals, INC | $14.94 | 2023 | Xarelto |
| Atricure, INC. | $14.23 | 2022 | |
| W. L. Gore & Associates, INC. | $12.53 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Volk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.